Clinical Trial Update: Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis [Phase 2]

View source ↗

Summary

The document describes a Phase 2 clinical trial assessing three dose levels of NMD670 in adults with myasthenia gravis (including MuSK-positive cases) and notes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Musk-positive Myasthenia Gravis
• Myasthenia Gravis

Drugs mentioned

• NMD670

Snippet

Sponsor: NMD Pharma A/S | Conditions: Myasthenia Gravis, Myasthenia Gravis, MuSK | Phase 2 | Status: RECRUITING